What is Thermo Fisher Scientific Inc.'s (TMO) StockRank?

MoatMap's StockRank for Thermo Fisher Scientific Inc. (TMO) is 56/100, with a Hold signal. This is a composite score combining Quality (56), Value (33), and Momentum (61) factor ranks across MoatMap's 20,000+ stock universe.

Does Thermo Fisher Scientific Inc. have an economic moat?

Thermo Fisher Scientific Inc. (TMO) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Thermo Fisher Scientific Inc. a buy, hold, or sell?

MoatMap's current signal for Thermo Fisher Scientific Inc. (TMO) is Hold, based on a StockRank of 56/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Thermo Fisher Scientific Inc. in?

Thermo Fisher Scientific Inc. (TMO) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

TMO

HOLD

Thermo Fisher Scientific Inc. · Healthcare · United States · $211.2B · Avg Vol: $1.3B/d

StockRank

Get insider-trade alerts

P/E (TTM)

29.2x

ROE

13.5%

D/E

0.8x

Dividend %

0.3%

COMPANY DESCRIPTION

Thermo Fisher Scientific Inc. is the world leader in serving science, providing analytical instruments, laboratory equipment, reagents, consumables, and services for research, clinical diagnostics, and industrial applications. Its extensive product portfolio, integrated solutions, and high switching costs create a significant competitive moat. The company maintains a market-leading position across diverse scientific disciplines and geographies, making it an essential partner for global R&D and healthcare advancement.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	44.9B	42.9B	42.9B	44.6B	-0.3%	45.2B	47.8B	50.3B	6.2%
EPS	17.75	15.52	16.58	17.77	0.0%	18.00	19.51	21.31	9.5%
Shares	390.5M	386.6M	380.8M	376.2M	-3.7%	371.6M	—	—	—
Debt	34.5B	34.9B	31.3B	39.4B	4.5%	43.2B	—	—	—
Equity	44.0B	46.7B	49.6B	53.4B	6.7%	—	—	—	—
Op CF	9.2B	8.4B	8.7B	7.8B	-5.1%	8.3B	—	—	—
Inv CF	-2.2B	-5.1B	-5.8B	-4.0B	—	—	—	—	—
Fin CF	-2.8B	-3.6B	-6.8B	1.8B	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+19.5%

SMA 50SMA 200

$568.26

RSI (14)

72.4

52W High

$642.71

From 52W High

0.9%

SCORE BREAKDOWN

Quality

ROIC

9.2%71.7

ROE

13.5%79.7

GP/Assets

16.8%40.5

Op. Margin

17.9%80.2

FCF/Assets

5.0%69.5

Piotroski

550.0

Int. Cover

6.2x54.3

D/E Ratio

0.83x18.0

Current Ratio

1.53x26.2

Value

P/E (TTM)

29.2x39.1

EV/EBITDA

20.9x28.9

P/FCF

38.3x36.0

P/B

3.8x35.8

P/S

4.3x45.6

Div Yield

0.3%5.5

Momentum

52W High %

88%83.8

RS 6M

-19%49.9

SMA 50/200

0.93x48.3

EPS Rev 4W

+0.0%75.3

EPS Rev 12W

-0.4%50.1

EPS Improve

+51%55.4

Q Growth

10%50.1

FUNDAMENTALS

Market Cap

$211.2B

P/E (Forward)

19.3x

Gross Margin

40.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TMO are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
TMO	Thermo Fisher Scientific Inc.(you)	$211.2B	56	HOLD
DAP.DE	Danaher Corporation	$137.1B	56	HOLD
IDXX	IDEXX Laboratories, Inc.	$42.9B	59	HOLD
NTRA	Natera, Inc.	$37.5B	52	HOLD
LONN.SW	Lonza Group AG	$46.1B	44	HOLD
WAT	Waters Corporation	$36.8B	65	BUY
IQV	IQVIA Holdings Inc.	$34.7B	67	BUY
GH	Guardant Health, Inc.	$19.5B	47	HOLD
ICLR	ICON Public Limited Company	$12.8B	57	HOLD
A	Agilent Technologies, Inc.	$32.5B	77	BUY

Peer medians: ROE 2.1% · P/E 23.4x · Gross margin 50.2%

Thermo Fisher Scientific Inc. (TMO) — Stock Score Summary

Thermo Fisher Scientific Inc. (TMO) has a MoatMap StockRank of 56/100 based on Quality (56/100), Value (33/100), and Momentum (61/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price	$568.26
Market Cap	$211.2B
P/E (TTM)	29.23
P/E (Forward)	19.31
Price/Book	3.77
Return on Equity	13.5%
Return on Invested Capital	9.2%
Debt/Equity	0.83x
Gross Margin	40.9%
Operating Margin	17.9%
Revenue Growth	6.2%
Dividend Yield	0.3%
Free Cash Flow	$5.5B

Thermo Fisher Scientific Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Thermo Fisher Scientific Inc.’s (TMO) StockRank?: MoatMap’s StockRank for Thermo Fisher Scientific Inc. (TMO) is 56/100, with a Hold signal. It is a composite of Quality (56), Value (33), and Momentum (61) factor ranks across MoatMap’s 20,000+ stock universe.
Does Thermo Fisher Scientific Inc. have an economic moat?: Thermo Fisher Scientific Inc. (TMO) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Thermo Fisher Scientific Inc. a buy, hold, or sell?: MoatMap’s current signal for Thermo Fisher Scientific Inc. (TMO) is Hold, based on a StockRank of 56/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Thermo Fisher Scientific Inc. in?: Thermo Fisher Scientific Inc. (TMO) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).